These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 33519716)

  • 21. Synthesis, conformation, and activity of human insulin-like peptide 5 (INSL5).
    Akhter Hossain M; Bathgate RA; Kong CK; Shabanpoor F; Zhang S; Haugaard-Jönsson LM; Rosengren KJ; Tregear GW; Wade JD
    Chembiochem; 2008 Jul; 9(11):1816-22. PubMed ID: 18576448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. INSL5-deficient mice display an alteration in glucose homeostasis and an impaired fertility.
    Burnicka-Turek O; Mohamed BA; Shirneshan K; Thanasupawat T; Hombach-Klonisch S; Klonisch T; Adham IM
    Endocrinology; 2012 Oct; 153(10):4655-65. PubMed ID: 22822165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relaxin-3, INSL5, and their receptors.
    Liu C; Lovenberg TW
    Results Probl Cell Differ; 2008; 46():213-37. PubMed ID: 18236022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-throughput screening campaign identifies a small molecule agonist of the relaxin family peptide receptor 4.
    Lin GY; Lin L; Cai XQ; Dai AT; Zhu Y; Li J; Liu Q; Yang DH; Bathgate RAD; Wang MW
    Acta Pharmacol Sin; 2020 Oct; 41(10):1328-1336. PubMed ID: 32235863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin-like peptide 5 is an orexigenic gastrointestinal hormone.
    Grosse J; Heffron H; Burling K; Akhter Hossain M; Habib AM; Rogers GJ; Richards P; Larder R; Rimmington D; Adriaenssens AA; Parton L; Powell J; Binda M; Colledge WH; Doran J; Toyoda Y; Wade JD; Aparicio S; Carlton MB; Coll AP; Reimann F; O'Rahilly S; Gribble FM
    Proc Natl Acad Sci U S A; 2014 Jul; 111(30):11133-8. PubMed ID: 25028498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Engineering of chimeric peptides as antagonists for the G protein-coupled receptor, RXFP4.
    Praveen P; Bathgate RAD; Hossain MA
    Sci Rep; 2019 Nov; 9(1):17828. PubMed ID: 31780677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Developing insulin-like peptide 5-based antagonists for the G protein-coupled receptor, RXFP4.
    Wu H; Handley TNG; Hoare BL; Hartono HA; Scott DJ; Chalmers DK; Bathgate RAD; Hossain MA
    Biochem Pharmacol; 2024 Jun; 224():116239. PubMed ID: 38679208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Engineering of a Novel Simplified Human Insulin-Like Peptide 5 Agonist.
    Patil NA; Hughes RA; Rosengren KJ; Kocan M; Ang SY; Tailhades J; Separovic F; Summers RJ; Grosse J; Wade JD; Bathgate RA; Hossain MA
    J Med Chem; 2016 Mar; 59(5):2118-25. PubMed ID: 26824523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin-like peptide 5 is a microbially regulated peptide that promotes hepatic glucose production.
    Lee YS; De Vadder F; Tremaroli V; Wichmann A; Mithieux G; Bäckhed F
    Mol Metab; 2016 Apr; 5(4):263-270. PubMed ID: 27069866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure of human insulin-like peptide 5 and characterization of conserved hydrogen bonds and electrostatic interactions within the relaxin framework.
    Haugaard-Jönsson LM; Hossain MA; Daly NL; Craik DJ; Wade JD; Rosengren KJ
    Biochem J; 2009 May; 419(3):619-27. PubMed ID: 19178384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. International Union of Basic and Clinical Pharmacology. XCV. Recent advances in the understanding of the pharmacology and biological roles of relaxin family peptide receptors 1-4, the receptors for relaxin family peptides.
    Halls ML; Bathgate RA; Sutton SW; Dschietzig TB; Summers RJ
    Pharmacol Rev; 2015; 67(2):389-440. PubMed ID: 25761609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of INSL5, a new member of the insulin superfamily.
    Conklin D; Lofton-Day CE; Haldeman BA; Ching A; Whitmore TE; Lok S; Jaspers S
    Genomics; 1999 Aug; 60(1):50-6. PubMed ID: 10458910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and recombinant expression of insulin-like peptide 5 precursors and the preparation of mature human INSL5.
    Luo X; Bathgate RA; Zhang WJ; Liu YL; Shao XX; Wade JD; Guo ZY
    Amino Acids; 2010 Nov; 39(5):1343-52. PubMed ID: 20383778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human Insulin-like Peptide 5 (INSL5). Identification of a Simplified Version of Two-Chain Analog A13.
    Zhang X; Bathgate RAD; Hossain MA
    ACS Med Chem Lett; 2020 Dec; 11(12):2455-2460. PubMed ID: 33335667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Japanese medaka as a model for studying the relaxin family genes involved in neuroendocrine regulation: Insights from the expression of fish-specific rln3 and insl5 and rxfp3/4-type receptor paralogues.
    Alnafea H; Vahkal B; Zelmer CK; Yegorov S; Bogerd J; Good SV
    Mol Cell Endocrinol; 2019 May; 487():2-11. PubMed ID: 30703485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin-Like Peptide 5 Interacts with Sex Hormones and Metabolic Parameters in a Gender and Adiposity Dependent Manner in Humans.
    Wagner IV; Flehmig G; Scheuermann K; Löffler D; Körner A; Kiess W; Stumvoll M; Dietrich A; Blüher M; Klöting N; Söder O; Svechnikov K
    Horm Metab Res; 2016 Sep; 48(9):589-94. PubMed ID: 27355242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ligand recognition mechanism of the human relaxin family peptide receptor 4 (RXFP4).
    Chen Y; Zhou Q; Wang J; Xu Y; Wang Y; Yan J; Wang Y; Zhu Q; Zhao F; Li C; Chen CW; Cai X; Bathgate RAD; Shen C; Eric Xu H; Yang D; Liu H; Wang MW
    Nat Commun; 2023 Jan; 14(1):492. PubMed ID: 36717591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. INSL5 is a high affinity specific agonist for GPCR142 (GPR100).
    Liu C; Kuei C; Sutton S; Chen J; Bonaventure P; Wu J; Nepomuceno D; Kamme F; Tran DT; Zhu J; Wilkinson T; Bathgate R; Eriste E; Sillard R; Lovenberg TW
    J Biol Chem; 2005 Jan; 280(1):292-300. PubMed ID: 15525639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Body Weight Reduction by Bariatric Surgery Reduces the Plasma Levels of the Novel Orexigenic Gut Hormone Insulin-like Peptide 5 in Patients with Severe Obesity.
    Di Vincenzo A; Crescenzi M; Granzotto M; Zancaner S; Fabris R; Foletto M; Prevedello L; Capone F; Vettor R; Rossato M
    J Clin Med; 2023 May; 12(11):. PubMed ID: 37297947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liquid chromatography/mass spectrometry based detection and semi-quantitative analysis of INSL5 in human and murine tissues.
    Kay RG; Galvin S; Larraufie P; Reimann F; Gribble FM
    Rapid Commun Mass Spectrom; 2017 Dec; 31(23):1963-1973. PubMed ID: 28857318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.